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Abstract
Background: The zinc finger transcription factor EGR-2 has been shown to play an important role in the induction of T cell
anergy and the regulation of peripheral T cell tolerance. In vitro, a prior study has show that T cells deficient in EGR-2 are
hyperproliferative to IL-2 and produce elevated levels of the effector cytokine IFN-c. EGR-2 deficient mice have increased
levels of CD44
high T cells in peripheral lymphoid organs, and with age, develop autoimmune-like features.
Principal Findings: Here we show that despite increased numbers of cells bearing an activated CD44
highCD62L
low
phenotype, T cells from young healthy EGR-2 deficient mice have normal proliferative and cytokine responses, and the mice
themselves mount normal immune responses against minor histocompatibility antigens, and the pathogens Toxoplasma
gondii and lymphocytic choriomeningitis virus.
Conclusions: Our results indicate that EGR-2 is not required to mount normal acute in vivo immune responses against
foreign antigens, and suggest instead that it may serve to regulate the response to chronic antigenic exposure, such as that
which occurs to autoantigens.
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Introduction
The early growth response (EGR) family of zinc finger
transcription factors includes 4 known members, which have
important functions in the central nervous system, cancer,
hematopoiesis, and immunological tolerance [1–4]. These tran-
scription factors are expressed in T cells; among these, EGR1–3
are upregulated after T cell receptor (TCR) stimulation [5,6].
While EGR-1 has been shown to be a positive regulator of T cell
activation [7,8], EGR-2 and EGR-3 have been shown to play a role
in T cell anergy induction [4,9–11]. In vitro, both EGR-2 and EGR-
3 are highly expressed in T cells activated under anergizing
conditions, such as stimulation through the T cell receptor in the
absence of costimulation or exposure to ionomycin [10–11], and
their expression is blocked by the calcineurin inhibitor cyclosporine
A, which prevents anergy induction in T cells [6]. EGR-2 mRNA
and protein levels, unlike those of EGR-3, remain upregulated for
days following anergy induction, suggesting that it has a significant
role in the induction of T cell anergy [10–11]. Moreover, treatment
of T cells with siRNA to inhibit EGR-2 expression restores IL-2
production and proliferation of in vitro anergized T cells, indicating
that EGR-2 is required for anergy induction [10].
EGR-2 has also been implied to play an important role in T cell
tolerance in vivo. T cells specific for the influenza hemagglutinin
antigen (HA) transferred into the tolerizing model of C3-HA mice,
which express HA as a self-antigen, are induced to express high
levels of EGR-2 [11]. More importantly, mice with T cell specific
EGR-2 deficiency have increased numbers of CD44
high T cells,
and develop an autoimmune-like illness with anti-DNA and anti-
histone antibodies, elevated serum IgG2a, glomerulonephritis,
inflammatory infiltrates in the liver and kidney, and skin lesions,
and with its onset at 1 year of age and a median survival of 15
months. This syndrome was shown to be T cell-driven, as
demonstrated by the transfer of EGR-2 deficient T cells into
RAG22/2 mice [12].
Although EGR-2 does not seem to play a role in the initial steps
of T cell activation, EGR-2 deficient T cells were observed to be
hyperresponsive to exogenous IL-2 following primary stimulation
[12] and to express increased amounts of the effector cytokines
IFN-c and IL-17 after activation [12]. Furthermore, EGR-2 has
been shown to induce the expression of FasL in activated T cells
[13,14]. Given these results it has been proposed that EGR-2
might also regulate effector T cell responses, in addition to
tolerance induction [4,12].
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previous reported. Here, using mice with T cell specific targeting
of EGR-2, we have tested its T cell intrinsic role during in vivo T
cell responses including those to minor histocompatibility antigens,
and LCMV and Toxoplasma gondii infections. Contrary to our
hypothesis that EGR-2 deficiency would lead to exaggerated T
cells responses, we find that EGR-2 deficient mice mount a normal
in vivo T cell responses with a peak and contraction face
comparable to that seen in wild-type animals.
Results
Increased levels of CD44 on T cells from EGR-2
conditional knockout mice
As previously reported, EGR-2 deficient mice are perinatally
lethal [15], therefore, in order to analyze the roleof EGR-2 in T cell
responses in vivo, we crossed EGR-2
flox/flox mice to CD4-Cre mice
(mice used for subsequent studies reported in this paper were
backcrossed onto a B6 background for at least 10 generations).
Western blot analysis of the Cre-expressing progeny confirmed the
absence ofdetectable EGR-2proteininactivated T cells(Figure1a).
Consistent with a prior report [12], analysis of the spleen, lymph
node andthymusshowedsimilarcellularityinEGR-2deficientmice
compared to WT controls, suggesting no obvious defect in
lymphocyte development (Figure 1b). Further analysis of the spleen
and lymph nodes shows similar percentages of CD8 T cells and a
small decrease in the percentage of CD4 T cells in both of these
organs(Figure 1c).Wenotedthat TcellspecificEgr-2deficientmice
have higher percentages of CD4
+CD44
high and CD8
+CD44
high T
cells in spleen and lymph nodes (Figure 1d and 1e), indicative of the
accumulation of activated cells in secondary lymphoid tissue. This
findingis consistentwith a previousstudy[12], althoughoccurred at
a somewhat earlier age in our colony, and suggests suggests that
EGR-2 may play a role in the regulation of T cell activation or
effector T cell homeostasis.
EGR-2 deficient T cells show normal proliferation and
cytokine production
The observation of increased cytokine production of EGR-2-
deficient T cells [12], along with the presence of elevated numbers
of CD44
high cells in EGR-2-deficient mice (ref. 12 and Figure 1),
led us to hypothesize that EGR-2 CKO mice would have
exaggerated T cell responses. To test this, we first analyzed the
response of purified T cells from 3 month old mice following in vitro
stimulation with plate-bound antibodies against CD3 +/2 CD28.
Despite the elevation in the percentage of activated T cells
(Figure 1), and consistent with previously published data [12],
EGR-2 deficient CD4 T cells showed normal proliferation and IL-
2 production in response to TCR stimulation (Figure 2a and 2b).
IFN-c production was also similar between EGR-2 KO and WT
CD4 T cells, after activation with anti-CD3 plus APCs antigen
presenting cells (APC) for 3 days (Figure 2c).
T cell response to minor histocompatibility antigens
To begin to analyze in vivo responses in EGR-2 CKO mice, we
first used examined the response to allogeneic antigens using a
minor histocompatibilty mismatch model. Proteins expressed on the
Y chromosome are only found in males and can be recognize by the
immune system of female mice as alloantigens, inducing an immune
response that is mediated by both CD4 and CD8 T cells. We
injected cells from male mice into the footpad of female mice and
followed the immune response by analyzing the increase in cell
numbersinthedraininglymphnode,compared tothenon-draining
lymph node (Figure 3). At day six after the footpad injection we
observed a roughly six fold increase in cells in the draining lymph
node (compared to cell numbers in the contralateral non-draining
node). This response was seen to peak at day 9, with up to a 28 fold
increaseincellnumbers.A comparable increaseincellnumberswas
seen in both the WT and CKO mice, indicating that EGR-2
deficient mice are capable of mounting a normal immune response
against minor histocompatibility antigens. Surprisingly, examina-
tion of cell numbers at day 14 revealed a similar physiologic
contraction of cell numbers, demonstrating normal resolution of the
immune response in EGR-2-deficient T cells.
T cell response to Toxoplasma gondii
Toxoplasma gondii is a parasite that induces strong TH-1 type
responses mediated by both CD4 and CD8 T cells [16], which
produce high levels of IFN-c [17]. In order to test the response to
this parasite in EGR-2 deficient mice, 8 CKO and 8 WT mice
were infected with Toxoplasma gondii intraperitoneally and serum
IFN-c levels were measured at days 7 and 22 after infection
(Figure 4). As expected, infection with T. gondii induced high levels
of serum IFN-c in control mice at day 7 after infection. EGR-2
deficient mice showed similar levels of this cytokine, indicating that
they mounted a normal response against this parasite. Further-
more, the levels of IFN-c were similarly decreased by day 22 in
both WT and CKO mice, also indicating that EGR-2 deficient
mice had normal resolution of the response.
T cell response to LCMV
We next tested the response of EGR-2-deficient T cells to
LCMV. LCMV is a natural mouse pathogen that elicits a strong
virus-specific CD8 T cell response characterized by high levels of
IFN-c [18]. This is a particularly useful model system as it enables
the enumeration of antigen specific T cell populations using
MHC-class I tetramers. WT or EGR-2 CKO mice were infected
with the Armstrong strain of LCMV, which induces an acute
infection, and the virus-specific response was followed using
tetramers to identify CD8 T cells specific for the gp33 and np396
immunodominant epitopes. On day 8 of infection the number of
gp33 and np396-specific CD8 T cells in the spleen had increased
in both WT and EGR-2 CKO mice, compared to that on day 5
(Figure 5a). As the numbers of tetramer positive cells on day 5
were no different than that of an un-infected control (data not
shown), this indicates that there was a normal expansion of virus-
specific CD8 T cells in EGR-2 CKO mice. Moreover, the
numbers of gp33 and np396-specific CD8 T cells showed a similar
decline by day 15 in both WT and EGR-2 CKO mice, indicating
a normal contraction phase.
In addition to enumerating antigen responsive T cells we also
tested their function as assessed by IFN-c production following ex
Figure 1. EGR-2 deficient mice have elevated levels of CD44 high T cells. (A) Western blot analysis of lysates from MACS-purified CD4 T cells
that left untreated (lanes 1,4,7) or stimulated for 15 hours with CD3 (1mg/mL) (lanes 2,5,8) or CD3 (1mg/mL) and CD28 (5mg/mL) (lanes 3,6,9). (B) Total
cell counts from WT (gray) or EGR-2 deficient mice (black). (C) Percentages of CD4
+ and CD8
+ T cells in spleen (SPL) and lymph nodes (LN), which were
obtained through flow cytometric analysis. (D) Percentages of CD44
high cells from spleen and lymph nodes analyzed through flow cytometry and
calculated after gating on CD4
+ or CD8
+ T cells. All graphs show results from three mice from each genotype. (E) Levels of CD44 and CD62L for CD4
and CD8 T cells in spleen of EGR-2 CKO or WT mice. Gates represent the percentage of activated cells.
doi:10.1371/journal.pone.0012904.g001
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activation with anti-CD3 alone or anti-CD3 and anti-CD28 at the specified conditions. (B) IL-2 production from the cultures described above,
measured through ELISA. (C) IFN-c production of purified CD4 T cells after activation with anti-CD3 and antigen presenting cells, measured by ELISA.
doi:10.1371/journal.pone.0012904.g002
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infection, at the peak of the response, there was significant
induction (compared with day 5) of IFN-c production by CD8 T
cells in both WT and EGR-2 CKO mice, which correlates with an
increase in the number of LCMV-specific CD8 T cells (Figure 5b).
By day 15 after infection, the percentages of IFN-c positive cells
had declined in both sets of mice, reflecting the drop in tetramer
positive CD8 T cell frequency. These data further indicate that the
expansion, peak and contraction phase during a response to
LCMV are normal in EGR-2 deficient mice.
Discussion
EGR-2 has been implicated in the induction CD4 T cell anergy,
and the regulation of peripheral tolerance in vivo. A previous study
has reported that mice that are deficient in EGR-2 show symptoms
of autoimmunity and have elevated levels of activated CD4 T cells
in peripheral lymphoid organs [12], suggesting that this transcrip-
tion factor plays an important role in the prevention of T cell
responses against self antigens. Those investigators also found that
CD4 T cells from EGR-2 deficient mice were hyperproliferative in
response to IL-2 re-stimulation and expressed higher levels of
effector cytokines such as IFN-c and IL-17 in vitro [12], which
suggested that EGR-2 might also play a role in the regulation of
CD4 T cells responses in vivo. However, the results we present in this
report indicate that EGR-2 deficient mice mount a normal immune
T cell immune response in vivo, comparable to that of WT mice.
Using a model of minor histocompatibility mismatch, we found
that EGR-2 deficient mice show a normal increase in cellularity in
draining lymph nodes and a normal contraction phase, as
compared to WT littermates. We have also shown that in
response to T. gondii infection, EGR-2 CKO mice have a
physiologic increase in IFN-c levels in the serum at the peak of
the response, and these decrease normally during the contraction
phase. Lastly, using tetramers to analyze antigen-specific CD8 T
cells we observed that after LCMV infection, EGR-2 deficient
mice have a normal increase in CD8 T cells specific to two major
epitopes, gp33 and np396. The number of antigen-specific CD8 T
cells also declined appropriately during the contraction phase.
Furthermore, the percentages of IFN-c secreting cells in response
to LCMV were comparable between EGR-2 CKO mice and WT
littermates at different stages of infection.
These results differ in some respects from those of Zhu et al.
[12], in that we did not observe an increase in IFN-c production in
EGR-2 deficient CD4 T cells. While the reasons for this are not
immediately apparent, they could be due to differing stimulation
Figure 3. EGR-2 deficient female mice mount a normal
response against the Y antigens. Female WT or EGR-2 deficient
mice were injected in the footpad with 20 million total splenocytes
from WT male mice. The number of cells in the draining (DLN) and non-
draining (NDLN) lymph nodes was calculated and the ratio of DNL/
DNLN is shown as fold increase in cellularity. Each condition includes
three mice of each genotype.
doi:10.1371/journal.pone.0012904.g003
Figure 4. EGR-2 deficient mice produce normal levels of INF-g in response to T. gondii infection. WT (white) or EGR-2 CKO (black) mice
were infected with T. gondii. The levels of IFN-c in the serum were measured on days 7 and 22 through ELISA. Each circle represents a single mouse.
doi:10.1371/journal.pone.0012904.g004
EGR-2 and T Cells
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were more extensively backcrossed onto a B6 background, which
tends to be less autoimmune prone.
Our results indicate that EGR-2 deficient mice can mount
normal in vivo T cell responses when they are challenged with three
different classes of antigens – minor histocompatibility antigen,
Figure 5. EGR-2 deficient mice mount a normal T cell response against LCMV. WT or EGR-2 CKO mice were infected with 2610
5 PFU of
LCMV Armstrong. (A) The number of CD8 T cells specific for gp33 or np396 was measured by staining with MHC-class I tetramers, on days 5, 8, and 15.
(B) The percentage of CD8 cells that were IFN-c producers was analyzed by intracellular cytokine staining after restimulation with LCMV pooled
peptide. For all graphs, three mice were analyzed for each genotype on each time point.
doi:10.1371/journal.pone.0012904.g005
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these findings contrast with published evidence indicating a role
for EGR-2 in regulating tolerance to self-antigens [12]. It is
tempting to speculate that the difference in the role of EGR-2 in
the response to foreign vs. self-antigens may lie in the different
contexts (inflammatory vs. non-inflammatory) in which foreign
and self-antigens are typically presented. However it is important
to note that all of our studies were performed on young healthy
mice. It is certainly possible that older mice with autoimmunity
would have dysregulated responses to foreign antigens. Thus our
primary conclusion is that loss of EGR-2 in T cells does not, per se,
interfere with a normal response to pathogens in otherwise healthy
animals.
Materials and Methods
Mice
EGR-2 floxed mice have been previously described [19]. They
have been crossed to the B6 background for more than 10
generations. CD4 Cre mice were purchased from The Jackson
Laboratories. Mice were kept in a barrier facility at the University
of Pennsylvania, and transferred to a BSL2 facility prior to the T.
gondii and LCMV infections. In all experiments, mice used were
2–3 months of age, prior to the onset of autoimmune symptoms.
Western Blot
MACS-purified CD4 T cells from spleen and lymph nodes of
either WT or EGR-2 CKO mice were cultured for 15 hours in
complete media alone or with plate-bound anti-CD3 (1mg/mL) or
both anti-CD3 (1mg/mL) and anti-CD28 (5mg/mL). Cell lysates
were analyzed as described in [20] for the presence of EGR-2
protein using an anti-EGR-2 antibody (Covance), or anti-actin as
control.
CD4 T cell culture and measurement of cytokine
production
CD4 T cells were MACS purified using a negative selection kit
from Miltenyi. T cells were CFSE labeled and culture at the stated
concentrations of anti-CD3 +/2 anti-CD28. Proliferation was
analyzed after three days of culture. IL-2 was analyzed from
supernatants obtained after 20 hours of culture and measured
through ELISA. IFN-c was analyzed from supernatants taken
after three days of culture and analyzed by ELISA.
Minor histocompatibility mismatch responses
Female WT or EGR-2 CKO mice were injected in the right
footpad with 20 million splenocytes from male WT mice in 50mlo f
PBS. On days 6, 9 and 14 after injection the number of cells in the
draining (right) versus non-draining (left) lymph nodes were
calculated.
Toxoplasma gondii infection
WT and EGR-2 CKO mice were injected intraperitoneally with
Toxoplasma gondii, using 20 cysts per mouse in 100ml of PBS. Mice
were bled at days 7 and 22 after infection. Levels of IFN-c in the
serum were measured through ELISA (BD Biosciences Kit).
LCMV infection
WT and EGR-2 CKO mice were injected intraperitoneally with
the Armstrong strain of LCMV (gift from Dr. John Wherry). Each
mouse received 2610
5 PFU in 500ml of PBS. On days 5, 8 and 15,
spleens were collected. The number of tetramer positive cells in
the spleen was analyzed using allophycocyanin-conjugated MHC
class I tetramers of H-2Db complexed with LCMV gp33–41 or
np396–404 (both gifts of Dr. John Wherry, Wistar Institute).
Splenocytes were re-stimulated ex-vivo with a pooled LCMV
peptide at 2mg/mL (gift of Dr. John Wherry), which is a mixture of
np396–404, np205–212, np166–175, np235–243, gp33–41,
gp276–286, gp118–125, gp92–101, and gp70–77, plus golgi stop
(BD intracellular stain kit) for 5 hours and the percentage of IFN-c
positive CD8 T cells was analyzed through flow cytometry.
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